CompoAtlas

HOGA BAO REN POWDER

HOGA BAO REN POWDER : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Ligusticum chuanxiongLigusticum chuanxiong[0.36 g,1.00 g]Not identified
Panax notoginsengPanax notoginseng[0.18 g]Not identified
Panax quinquefoliusPanax quinquefolius[0.18 g]Not identified
Aquilaria sinensisAquilaria sinensis[0.28 g,1.00 g]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL17126006TC
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
Gaharu Technologies Sdn. Bhd.
Manufacturer
ENVIROTECH INDUSTRY SDN BHD
Registration period starting
2023-03-02
Published validity end
2028-03-02

Original register data

View published fields and their variants
Active ingredients
Ligusticum chuanxiong[0.36 g,1.00 g],Panax notoginseng[0.18 g],Panax quinquefolius[0.18 g],Aquilaria sinensis[0.28 g,1.00 g]
Valid until
2028-03-02
Registration date
2023-03-02
Published description
NATURAL PRODUCT
Licence holder
Gaharu Technologies Sdn. Bhd.
Producer
ENVIROTECH INDUSTRY SDN BHD
Published name
HOGA BAO REN POWDER
Published reference
201706220473T
Registration number
MAL17126006TC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL17126006TC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Panax quinquefolius
    Read the warning, when it applies and the studies cited

    PANAX QUINQUEFOLIUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or digoxin (Brinker 2010; Dasgupta et al. 2007; Elmer et al. 2007; Yuan et al. 2004).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dasgupta A, Kang E, Olsen M, Actor JK, Datta P. Interference of Asian, American, and Indian (Ashwagandha) ginseng in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay. Archives of Pathology & Laboratory Medicine 2007;131(4):619-621. PubMed
    • Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. The Annals of Pharmacotherapy 2007;41(10):1617-1624. PubMed
    • Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. American ginseng reduces warfarin's effect in healthy patients. Annals of internal medicine 2004;141(1):23-27. PubMed Randomised trial

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Dascalu et al. 2007; Vuksan et al. 2000a,b,c).

    Sources cited by Health Canada (3)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Dascalu A, Sievenpiper JL, Jenkins AL, Stavro MP, Leiter LA, Arnason JT, Vuksan V. Five batches representative of Ontario-grown American ginseng root produce comparable reductions of postprandial glycemia in healthy individuals. Canadian Journal of Physiology and Pharmacology 2007;85(9):856-864. PubMed
    • Vuksan V, Xu Z, Jenkins AL, Belgan U, Sievenpiper JL, Leiter LA, Josse RG, Stavro MP.American ginseng (Panax quinquefolium L.) improves long-term glycemic control in type 2 diabetes: double-blind placebo controlled crossover trial. Diabetes 2000a;49 (Suppl.1):A95.

    Condition of application: All products except Glucose levels and Adaptogen - immune system.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “HOGA BAO REN POWDER”, https://compoatlas.com/en/supplements/malaysia/MAL17126006TC-hoga-bao-ren-powder, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line